4-[[(Indol-6-yl)carbonyl]amino]butanoic acid, methyl ester, 1g

Columna HPLC NUCLEODUR® 100-3 C8 ec, 250 mm, 4,6 mm, 1 Pieza(s)

2-Acetylpyridine, 98.0%, 500g

4-(3-Bromo-5-nitropyridin-2-yl)morpholine, 95.0%, 5g

1-(Difluoromethoxy)-2-ethynylbenzene, 96%, 250mg

(S)-2-Amino-3-(furan-2-yl)propanoic acid, 95.0%, 500mg

Methyl 3-bromopyrazolo[1,5-a]pyridine-5-carboxylate, 98%, 250mg

Lumazine>99.0%(T)1g

8-Methoxyquinoline-2-carboxylic acid, 95.0%, 1g

6-chloro-4H,7H-thieno[2,3-b]pyridin-4-one, 95%, 1g

3'-Methyl-2,2,2-trifluoroacetophenone, 97.0%, 25g

(2R,3R,4R,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 97%, 100g

o-Anisidina, >=98%, para síntesis, 250 ml, envase de vidrio